Version 5.4
Homo sapiens Protein: PNMA2
Summary
InnateDB Protein IDBP-476566.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PNMA2
Protein Name paraneoplastic antigen MA2
Synonyms MA2; MM2; RGAG2;
Species Homo sapiens
Ensembl Protein ENSP00000429344
InnateDB Gene IDBG-402999 (PNMA2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Nucleus, nucleolus {ECO:0000269PubMed:10050892}.
Disease Associations
Tissue Specificity Brain-specific. In some cancer patients, specifically expressed by testicular tumor cells. {ECO:0000269PubMed:10362822, ECO:0000269PubMed:19366867}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 19 experimentally validated interaction(s) in this database.
Experimentally validated
Total 19 [view]
Protein-Protein 19 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0043065 positive regulation of apoptotic process
Cellular Component
GO:0005730 nucleolus
Protein Structure and Domains
PDB ID
InterPro IPR005162 Retrotransposon gag domain
PFAM PF03732
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9UL42
PhosphoSite PhosphoSite-Q9UL42
TrEMBL
UniProt Splice Variant
Entrez Gene 10687
UniGene Hs.655252
RefSeq NP_009188
HUGO HGNC:9159
OMIM 603970
CCDS CCDS34868
HPRD
IMGT
EMBL AB020690 AF037365 AF083114 AF083115 AF286487 AK055325 BC047515 BC062301 CH471080
GenPept AAD02098 AAF05625 AAF05626 AAG28165 AAH47515 AAH62301 BAA74906 BAG51501 EAW63575

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca